Profile picture

Doctor Masato Kawasaki

Osaka General Medical Center, Osaka (Japan)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Prognostic value of atrial fibrillation duration and left atrial low-voltage area after atrial fibrillation ablation: insights from the SUPPRESS AF study
Presentation
Prognostic value of atrial fibrillation duration and left atrial low-voltage area after atrial fibrillation ablation: insights from the SUPPRESS AF study
Prognostic value of serum chloride levels in patients with implantable cardioverter defibrillators, relating to heart failure
Presentation
Prognostic value of serum chloride levels in patients with implantable cardioverter defibrillators, relating to heart failure
Prognostic value of modified ADMIIRE-HF risk score in patients with implantable cardioverter defibrillator: a prospective comparative study with 6-minute walk distance
Presentation
Prognostic value of modified ADMIIRE-HF risk score in patients with implantable cardioverter defibrillator: a prospective comparative study with 6-minute walk distance
Prognostic value of nutritional status in patients with heart failure with preserved ejection fraction, with and without atrial fibrillation: Insights From PURSUIT-HFpEF Registry
Presentation
Prognostic value of nutritional status in patients with heart failure with preserved ejection fraction, with and without atrial fibrillation: Insights From PURSUIT-HFpEF Registry
Impact of paroxysmal atrial fibrillation ablation on cardiac sympathetic nervous system: a prospective randomized comparative study with cryoballoon catheter or radiofrequency ablation catheter
Presentation
Impact of paroxysmal atrial fibrillation ablation on cardiac sympathetic nervous system: a prospective randomized comparative study with cryoballoon catheter or radiofrequency ablation catheter
Modified ADMIRE-HF risk score predicts serious arrhythmic events in patients with implantable cardioverter defibrillator, regardless of left ventricular ejection fraction
Presentation
Modified ADMIRE-HF risk score predicts serious arrhythmic events in patients with implantable cardioverter defibrillator, regardless of left ventricular ejection fraction

ESC 365 is supported by